Table 4B. Results of joinpoint regression analysis on the trends in site-specific cancer mortality: national data (1958–2018); Female.
Cancer site | ICD-10 | Number of joinpoints |
Line segment | Annual % change |
95% confidence interval |
||||
Start | End | Lower | Upper | ||||||
Major | |||||||||
Stomach | C16 | 4 | 1958 | 1970 | −0.8 | −1.0 | −0.6 | * | |
1970 | 1979 | −3.2 | −3.5 | −2.9 | * | ||||
1979 | 1991 | −4.4 | −4.6 | −4.2 | * | ||||
1991 | 1999 | −3.3 | −3.8 | −2.9 | * | ||||
1999 | 2018 | −3.9 | −4.0 | −3.8 | * | ||||
Colon | C18 | 5 | 1958 | 1982 | 3.4 | 3.3 | 3.5 | * | |
1982 | 1993 | 2.3 | 2.0 | 2.6 | * | ||||
1993 | 2004 | −0.4 | −0.7 | −0.2 | * | ||||
2004 | 2008 | −2.3 | −3.7 | −0.9 | * | ||||
2008 | 2014 | 0.4 | −0.2 | 1.0 | |||||
2014 | 2018 | −0.9 | −1.8 | 0.0 | |||||
Rectum | C19–C20 | 1 | 1958 | 1974 | 1.3 | 1.0 | 1.6 | * | |
1974 | 2018 | −1.3 | −1.3 | −1.2 | * | ||||
Colon/rectum | C18–C20 | 5 | 1958 | 1974 | 2.3 | 2.1 | 2.6 | * | |
1974 | 1992 | 1.1 | 1.0 | 1.3 | * | ||||
1992 | 2004 | −0.5 | −0.7 | −0.3 | * | ||||
2004 | 2009 | −2.1 | −3.0 | −1.2 | * | ||||
2009 | 2014 | 0.4 | −0.5 | 1.3 | |||||
2014 | 2018 | −1.1 | −2.0 | −0.2 | * | ||||
Liver | C22 | 4 | 1958 | 1975 | −2.4 | −2.6 | −2.1 | * | |
1975 | 1989 | 0.2 | −0.1 | 0.5 | |||||
1989 | 1999 | 1.4 | 0.9 | 1.8 | * | ||||
1999 | 2008 | −2.9 | −3.4 | −2.5 | * | ||||
2008 | 2018 | −5.7 | −6.1 | −5.4 | * | ||||
Pancreas | C25 | 5 | 1958 | 1967 | 6.4 | 5.5 | 7.4 | * | |
1967 | 1988 | 2.8 | 2.7 | 3.0 | * | ||||
1988 | 1994 | −0.4 | −1.3 | 0.5 | |||||
1994 | 2006 | 0.6 | 0.4 | 0.8 | * | ||||
2006 | 2011 | 2.1 | 1.1 | 3.1 | * | ||||
2011 | 2018 | 0.7 | 0.4 | 1.1 | * | ||||
Lung, trachea | C33–C34 | 5 | 1958 | 1963 | 6.5 | 4.2 | 8.8 | * | |
1963 | 1984 | 3.1 | 2.9 | 3.3 | * | ||||
1984 | 1998 | 0.9 | 0.7 | 1.1 | * | ||||
1998 | 2003 | −1.8 | −2.8 | −0.7 | * | ||||
2003 | 2014 | −0.2 | −0.4 | 0.1 | |||||
2014 | 2018 | −2.3 | −3.3 | −1.4 | * | ||||
Breast | C50 | 5 | 1958 | 1964 | −0.5 | −2.1 | 1.1 | ||
1964 | 1978 | 2.3 | 1.9 | 2.8 | * | ||||
1978 | 1990 | 1.5 | 1.1 | 1.9 | * | ||||
1990 | 1997 | 3.2 | 2.4 | 4.0 | * | ||||
1997 | 2006 | 1.4 | 0.9 | 1.8 | * | ||||
2006 | 2018 | 0.4 | 0.2 | 0.6 | * | ||||
Uterus | C53–C55 | 5 | 1958 | 1969 | −3.1 | −3.3 | −2.9 | * | |
1969 | 1979 | −4.4 | −4.8 | −4.1 | * | ||||
1979 | 1987 | −5.4 | −6.0 | −4.9 | * | ||||
1987 | 1993 | −3.1 | −4.1 | −2.1 | * | ||||
1993 | 2007 | −0.3 | −0.6 | −0.1 | * | ||||
2007 | 2018 | 1.0 | 0.7 | 1.3 | * | ||||
Cervix uteri | C53 | 4 | 1958 | 1965 | −1.9 | −3.3 | −0.5 | * | |
1965 | 1973 | −5.1 | −6.5 | −3.8 | * | ||||
1973 | 1978 | 1.0 | −2.4 | 4.6 | |||||
1978 | 1989 | −2.4 | −3.2 | −1.6 | * | ||||
1989 | 2018 | 0.4 | 0.3 | 0.6 | * | ||||
Corpus uteri | C54 | 3 | 1958 | 1966 | −6.2 | −8.1 | −4.3 | * | |
1966 | 1972 | −14.3 | −19.1 | −9.3 | * | ||||
1972 | 1996 | 4.3 | 3.8 | 4.7 | * | ||||
1996 | 2018 | 3.0 | 2.7 | 3.3 | * | ||||
Sub-major | |||||||||
Esophagus | C15 | 2 | 1958 | 1969 | −0.1 | −0.7 | 0.5 | ||
1969 | 1989 | −3.9 | −4.1 | −3.6 | * | ||||
1989 | 2018 | −0.7 | −0.9 | −0.6 | * | ||||
Gallbladder and bile ducts | C23–C24 | 4 | 1958 | 1963 | 12.0 | 9.0 | 15.1 | * | |
1963 | 1972 | 6.1 | 5.1 | 7.0 | * | ||||
1972 | 1985 | 4.1 | 3.7 | 4.4 | * | ||||
1985 | 1992 | 0.1 | −0.5 | 0.8 | |||||
1992 | 2018 | −3.1 | −3.1 | −3.0 | * | ||||
Ovary | C56 | 4 | 1958 | 1981 | 3.9 | 3.7 | 4.1 | * | |
1981 | 1996 | 1.3 | 1.1 | 1.6 | * | ||||
1996 | 2000 | −2.6 | −5.1 | 0.0 | * | ||||
2000 | 2011 | −0.2 | −0.6 | 0.2 | |||||
2011 | 2018 | −1.1 | −1.8 | −0.4 | * | ||||
Urinary bladder | C67 | 2 | 1958 | 1969 | 1.6 | 0.6 | 2.6 | * | |
1969 | 1990 | −1.7 | −2.0 | −1.4 | * | ||||
1990 | 2018 | −0.2 | −0.3 | 0.0 | * | ||||
Kidney and other urinary organs (except bladder) | C64–C66 C68 | 3 | 1958 | 1976 | 1.5 | 0.9 | 2.1 | * | |
1976 | 1986 | 3.8 | 2.6 | 5.1 | * | ||||
1986 | 2006 | 1.5 | 1.2 | 1.7 | * | ||||
2006 | 2018 | 0.0 | −0.4 | 0.4 | |||||
Thyroid | C73 | 2 | 1958 | 1977 | 1.9 | 1.5 | 2.4 | * | |
1977 | 2003 | −1.0 | −1.2 | −0.8 | * | ||||
2003 | 2018 | −1.8 | −2.1 | −1.4 | * | ||||
Malignant lymphoma | C81–C85 C96 | 3 | 1958 | 1981 | 2.5 | 2.3 | 2.7 | * | |
1981 | 2001 | 0.9 | 0.7 | 1.1 | * | ||||
2001 | 2006 | −2.2 | −3.8 | −0.5 | * | ||||
2006 | 2018 | 0.0 | −0.3 | 0.3 | |||||
Others | |||||||||
Oral cavity and pharynx | C00–C14 | 3 | 1958 | 1979 | 0.6 | 0.2 | 1.1 | * | |
1979 | 1991 | −0.8 | −1.7 | 0.0 | |||||
1991 | 1998 | 5.2 | 3.3 | 7.1 | * | ||||
1998 | 2018 | −0.5 | −0.8 | −0.3 | * | ||||
Larynx | C32 | 2 | 1958 | 1976 | −4.3 | −5.0 | −3.5 | * | |
1976 | 1986 | −9.0 | −11.3 | −6.6 | * | ||||
1986 | 2018 | −3.5 | −4.0 | −3.0 | * | ||||
Skin | C43–C44 | 3 | 1958 | 1973 | −1.8 | −2.8 | −0.8 | * | |
1973 | 1988 | −5.1 | −6.1 | −4.1 | * | ||||
1988 | 2012 | 0.8 | 0.3 | 1.3 | * | ||||
2012 | 2018 | −2.7 | −5.9 | 0.7 | |||||
Brain, nervous system | C70–C72 | 4 | 1958 | 1971 | 1.8 | −0.1 | 3.7 | ||
1971 | 1978 | 7.3 | 2.8 | 12.1 | * | ||||
1978 | 1998 | 1.5 | 1.0 | 2.1 | * | ||||
1998 | 2007 | −0.6 | −2.4 | 1.3 | |||||
2007 | 2018 | 3.2 | 2.1 | 4.3 | * | ||||
Multiple myeloma | C88–C90 | 4 | 1958 | 1968 | 14.8 | 11.9 | 17.9 | * | |
1968 | 1983 | 5.6 | 4.8 | 6.4 | * | ||||
1983 | 1997 | 1.5 | 1.0 | 1.9 | * | ||||
1997 | 2005 | −0.2 | −1.2 | 0.9 | |||||
2005 | 2018 | −2.6 | −3.0 | −2.2 | * | ||||
Leukemia | C91–C95 | 2 | 1958 | 1967 | 2.9 | 2.1 | 3.8 | * | |
1967 | 1987 | 0.6 | 0.4 | 0.8 | * | ||||
1987 | 2018 | −1.5 | −1.6 | −1.4 | * |
ICD-10, International Classification of Diseases, 10th revision.
*Annual % change was statistically significantly different from zero (P < 0.05).